ARTICLE| Volume 115, P54-67, November 2022

EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy


      • Loss of del(5q) gene, EGR1, imparts a clonal advantage to stem cells under stress.
      • Complete loss of EGR1 function is incompatible with malignant transformation.
      • EGR1 binds differentiation, inflammation, and DNA damage response genes.
      • Loss of EGR1 counteracts detrimental effects of inflammation on stem cells.
      • Enrichment of inflammatory genes within del(5q) region may confer fitness advantage.
      Therapy-related myeloid neoplasms (t-MNs) share many clinical and molecular characteristics with AML de novo in the elderly. One common factor is that they arise in the setting of chronic inflammation, likely because of advanced age or chemotherapy-induced senescence. Here, we examined the effect of haploinsufficient loss of the del(5q) tumor suppressor gene, EGR1, commonly deleted in high-risk MNs. In mice, under the exogenous stress of either serial transplant or successive doses of the alkylating agent N-ethyl-nitrosourea (ENU), Egr1-haploinsufficient hematopoietic stem cells (HSCs) exhibit a clonal advantage. Complete loss of EGR1 function is incompatible with transformation; mutations of EGR1 are rare and are not observed in the remaining allele in del(5q) patients, and complete knockout of Egr1 in mice leads to HSC exhaustion. Using chromatin immunoprecipitation sequencing (ChIP-seq), we identified EGR1 binding sites in human CD34+ cord blood-derived stem and progenitor cells (HSPCs) and found that EGR1 binds genes critical for stem cell differentiation, inflammatory signaling, and the DNA damage response. Notably, in the chromosome 5 sequences frequently deleted in patients, there is a significant enrichment of innate and inflammatory genes, which may confer a fitness advantage in an inflammatory environment. Short hairpin RNA (shRNA)-mediated silencing of EGR1 biases HSPCs toward a self-renewal transcriptional signature. In the absence of EGR1, HSPCs are characterized by upregulated MYC-driven proliferative signals, downregulated CDKN1A (p21), disrupted DNA damage response, and downregulated inflammation—adaptations anticipated to confer a relative fitness advantage for stem cells especially in an environment of chronic inflammation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Experimental Hematology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • McNerney ME
        • Godley LA
        • Le Beau MM
        Therapy-related myeloid neoplasms: when genetics and environment collide.
        Nat Rev Cancer. 2017; 17: 513-527
        • Appelbaum FR
        • Gundacker H
        • Head DR
        • et al.
        Age and acute myeloid leukemia.
        Blood. 2006; 107: 3481-3485
        • Bello C
        • Yu D
        • Komrokji RS
        • et al.
        Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.
        Cancer. 2011; 117: 1463-1469
        • Lindsley RC
        • Mar BG
        • Mazzola E
        • et al.
        Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
        Blood. 2015; 125: 1367-1376
        • Gillis NK
        • Ball M
        • Zhang Q
        • et al.
        Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case–control study.
        Lancet Oncol. 2017; 18: 112-121
        • Takahashi K
        • Wang F
        • Kantarjian H
        • et al.
        Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case–control study.
        Lancet Oncol. 2017; 18: 100-111
        • Kovtonyuk LV
        • Fritsch K
        • Feng X
        • Manz MG
        • Takizawa H.
        Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment.
        Front Immunol. 2016; 7: 502
        • Freund A
        • Orjalo AV
        • Desprez PY
        • Campisi J.
        Inflammatory networks during cellular senescence: causes and consequences.
        Trends Mol Med. 2010; 16: 238-246
        • Demaria M
        • O'Leary MN
        • Chang J
        • et al.
        Cellular senescence promotes adverse effects of chemotherapy and cancer relapse.
        Cancer Discov. 2017; 7: 165-176
        • Kartikasari AER
        • Huertas CS
        • Mitchell A
        • Plebanski M
        Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis.
        Front Oncol. 2021; 11692142
        • Takizawa H
        • Regoes RR
        • Boddupalli CS
        • Bonhoeffer S
        • Manz MG.
        Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation.
        J Exp Med. 2011; 208: 273-284
        • Takizawa H
        • Fritsch K
        • Kovtonyuk LV
        • et al.
        Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness.
        Cell Stem Cell. 2017; 21 (e225): 225-240
        • Caiado F
        • Pietras EM
        • Manz MG.
        Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection.
        J Exp Med. 2021; 218e20201541
        • Hormaechea-Agulla D
        • Matatall KA
        • Le DT
        • et al.
        Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
        Cell Stem Cell. 2021; 28 (e1426): 1428-1442
        • Muto T
        • Walker CS
        • Choi K
        • et al.
        Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs.
        Nat Immunol. 2020; 21: 535-545
        • Lai F
        • Godley LA
        • Joslin J
        • et al.
        Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
        Genomics. 2001; 71: 235-245
        • Sukhatme VP
        • Cao XM
        • Chang LC
        • et al.
        A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization.
        Cell. 1988; 53: 37-43
        • Milbrandt J.
        A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor.
        Science. 1987; 238: 797-799
        • Huang RP
        • Wu JX
        • Fan Y
        • Adamson ED.
        UV activates growth factor receptors via reactive oxygen intermediates.
        J Cell Biol. 1996; 133: 211-220
        • Christy B
        • Nathans D.
        DNA binding site of the growth factor-inducible protein Zif268.
        Proc Natl Acad Sci USA. 1989; 86: 8737-8741
        • Swirnoff AH
        • Milbrandt J.
        DNA-binding specificity of NGFI-A and related zinc finger transcription factors.
        Mol Cell Biol. 1995; 15: 2275-2287
        • Liu C
        • Calogero A
        • Ragona G
        • Adamson E
        • Mercola D.
        EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
        Crit Rev Oncog. 1996; 7: 101-125
        • Wang B
        • Guo H
        • Yu H
        • Chen Y
        • Xu H
        • Zhao G.
        The role of the transcription factor EGR1 in cancer.
        Front Oncol. 2021; 11642547
        • Joslin JM
        • Fernald AA
        • Tennant TR
        • et al.
        Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.
        Blood. 2007; 110: 719-726
        • Stoddart A
        • Wang J
        • Fernald AA
        • et al.
        Cytotoxic therapy-induced effects on both hematopoietic and marrow stromal cells promotes therapy-related myeloid neoplasms.
        Blood Cancer Discov. 2020; 1: 32-47
        • Coppé JP
        • Desprez PY
        • Krtolica A
        • Campisi J.
        The senescence-associated secretory phenotype: the dark side of tumor suppression.
        Annu Rev Pathol. 2010; 5: 99-118
        • Min IM
        • Pietramaggiori G
        • Kim FS
        • Passegué E
        • Stevenson KE
        • Wagers AJ.
        The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells.
        Cell Stem Cell. 2008; 2: 380-391
        • Burgess MR
        • Hwang E
        • Firestone AJ
        • et al.
        Preclinical efficacy of MEK inhibition in Nras-mutant AML.
        Blood. 2014; 124: 3947-3955
        • Das A
        • Chendil D
        • Dey S
        • et al.
        Ionizing radiation down-regulates p53 protein in primary Egr-1–/– mouse embryonic fibroblast cells causing enhanced resistance to apoptosis.
        J Biol Chem. 2001; 276: 3279-3286
        • Yu J
        • Baron V
        • Mercola D
        • Mustelin T
        • Adamson ED.
        A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
        Cell Death Differ. 2007; 14: 436-446
        • Boone DN
        • Qi Y
        • Li Z
        • Hann SR.
        Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.
        Proc Natl Acad Sci USA. 2011; 108: 632-637
        • Cerami E
        • Gao J
        • Dogrusoz U
        • et al.
        The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
        Cancer Discov. 2012; 2: 401-404
        • Gao J
        • Aksoy BA
        • Dogrusoz U
        • et al.
        Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
        Sci Signal. 2013; 6: pl1
        • Challen GA
        • Sun D
        • Jeong M
        • et al.
        Dnmt3a is essential for hematopoietic stem cell differentiation.
        Nat Genet. 2011; 44: 23-31
        • Giladi A
        • Paul F
        • Herzog Y
        • et al.
        Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis.
        Nat Cell Biol. 2018; 20: 836-846
        • Nguyen HQ
        • Hoffman-Liebermann B
        • Liebermann DA.
        The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
        Cell. 1993; 72: 197-209
        • Krishnaraju K
        • Hoffman B
        • Liebermann DA.
        Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages.
        Blood. 2001; 97: 1298-1305
        • Barbieri E
        • Trizzino M
        • Welsh SA
        • et al.
        Targeted enhancer activation by a subunit of the integrator complex.
        Mol Cell. 2018; 71 (e107): 103-116
        • Pietras EM.
        Inflammation: a key regulator of hematopoietic stem cell fate in health and disease.
        Blood. 2017; 130: 1693-1698
        • dW Huang
        • BT Sherman
        • Lempicki RA
        Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
        Nat Protoc. 2009; 4: 44-57
        • dW Huang
        • BT Sherman
        • Lempicki RA
        Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.
        Nucleic Acids Res. 2009; 37: 1-13
        • Sakamoto KM
        • Fraser JK
        • Lee HJ
        • Lehman E
        • Gasson JC.
        Granulocyte–macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter.
        Mol Cell Biol. 1994; 14: 5975-5985
        • Yao J
        • Mackman N
        • Edgington TS
        • ST Fan
        Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors.
        J Biol Chem. 1997; 272: 17795-17801
        • McLean CY
        • Bristor D
        • Hiller M
        • et al.
        GREAT improves functional interpretation of cis-regulatory regions.
        Nat Biotechnol. 2010; 28: 495-501
        • Lord KA
        • Abdollahi A
        • Hoffman-Liebermann B
        • Liebermann DA.
        Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation.
        Mol Cell Biol. 1993; 13: 841-851
        • Liebermann DA
        • Hoffman-Liebermann B.
        Genetic programs of myeloid cell differentiation.
        Curr Opin Hematol. 1994; 1: 24-32
        • Ragione FD
        • Cucciolla V
        • Criniti V
        • Indaco S
        • Borriello A
        • Zappia V.
        p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect.
        J Biol Chem. 2003; 278: 23360-23368
        • Krones-Herzig A
        • Mittal S
        • Yule K
        • et al.
        Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53.
        Cancer Res. 2005; 65: 5133-5143
        • Nair P
        • Muthukkumar S
        • Sells SF
        • Han SS
        • Sukhatme VP
        • Rangnekar VM.
        Early growth response-1-dependent apoptosis is mediated by p53.
        J Biol Chem. 1997; 272: 20131-20138
        • Elkon R
        • Zeller KI
        • Linhart C
        • Dang CV
        • Shamir R
        • Shiloh Y.
        In silico identification of transcriptional regulators associated with c-Myc.
        Nucleic Acids Res. 2004; 32: 4955-4961
        • Wirth M
        • Stojanovic N
        • Christian J
        • et al.
        MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib.
        Nucleic Acids Res. 2014; 42: 10433-10447
        • Stoddart A
        • Wang J
        • Fernald AA
        • Karrison T
        • Anastasi J
        • Le Beau MM
        Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc.
        Blood. 2014; 123: 228-238
        • Cook EK
        • Luo M
        • Rauh MJ.
        Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity.
        Exp Hematol. 2020; 83: 85-94
        • Cai Z
        • Kotzin JJ
        • Ramdas B
        • et al.
        Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis.
        Cell Stem Cell. 2018; 23 (e835): 833-849
        • Abegunde SO
        • Buckstein R
        • Wells RA
        • Rauh MJ.
        An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis.
        Exp Hematol. 2018; 59: 60-65
        • Terao C
        • Suzuki A
        • Momozawa Y
        • et al.
        Chromosomal alterations among age-related haematopoietic clones in Japan.
        Nature. 2020; 584: 130-135
        • Gao T
        • Ptashkin R
        • Bolton KL
        • et al.
        Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
        Nat Commun. 2021; 12: 338
        • Stalmann USA
        • Ticconi F
        • Snoeren IAM
        • et al.
        Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion.
        Blood Adv. 2022; 6: 1780-1796
        • Stoddart A
        • Fernald AA
        • Wang J
        • et al.
        Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.
        Blood. 2014; 123: 1069-1078
        • Sallman DA
        • List A.
        The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes.
        Blood. 2019; 133: 1039-1104
        • Gañán-Gómez I
        • Wei Y
        • Starczynowski DT
        • et al.
        Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.
        Leukemia. 2015; 29: 1458-1469
        • Pietras EM
        • Mirantes-Barbeito C
        • Fong S
        • et al.
        Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.
        Nat Cell Biol. 2016; 18: 607-618
        • Pietras EM
        • Lakshminarasimhan R
        • Techner JM
        • et al.
        Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.
        J Exp Med. 2014; 211: 245-262
        • Esplin BL
        • Shimazu T
        • Welner RS
        • et al.
        Chronic exposure to a TLR ligand injures hematopoietic stem cells.
        J Immunol. 2011; 186: 5367-5375
        • Trizzino M
        • Zucco A
        • Deliard S
        • et al.
        EGR1 is a gatekeeper of inflammatory enhancers in human macrophages.
        Sci Adv. 2021; 7: eaaz8836
        • Yu J
        • de Belle I
        • Liang H
        • Adamson ED.
        Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses.
        Mol Cell. 2004; 15: 83-94
        • Hole PS
        • Darley RL
        Tonks A. Do reactive oxygen species play a role in myeloid leukemias?.
        Blood. 2011; 117: 5816-5826
        • Stoddart A
        • Nakitandwe J
        • Chen SC
        • Downing JR
        • Le Beau MM
        Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms.
        Blood. 2015; 126: 2899-2901
        • Qian Z
        • Fernald AA
        • Godley LA
        • Larson RA
        • Le Beau MM
        Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.
        Proc Natl Acad Sci USA. 2002; 99: 14925-14930
        • Randall TD
        • Weissman IL.
        Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment.
        Blood. 1997; 89: 3596-3606
        • Novershtern N
        • Subramanian A
        • Lawton LN
        • et al.
        Densely interconnected transcriptional circuits control cell states in human hematopoiesis.
        Cell. 2011; 144: 296-309
        • Venezia TA
        • Merchant AA
        • Ramos CA
        • et al.
        Molecular signatures of proliferation and quiescence in hematopoietic stem cells.
        PLoS Biol. 2004; 2: e301